Role of Sphingosine Kinases in the Development of NAFLD and HCC
Access status:
USyd Access
Type
ThesisThesis type
Doctor of PhilosophyAuthor/s
Liu, XinAbstract
Sphingolipids are a class of essential lipids, serving as both building blocks of the cell membrane that facilitate cell growth and proliferation and acting as signalling molecules that dictate various cell functions. The liver stands as the primary site for sphingolipid metabolism ...
See moreSphingolipids are a class of essential lipids, serving as both building blocks of the cell membrane that facilitate cell growth and proliferation and acting as signalling molecules that dictate various cell functions. The liver stands as the primary site for sphingolipid metabolism in our bodies. Conversely, dysregulation of sphingolipids has been implicated in a broad range of liver diseases, such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic hepatosteatosis (NASH) and hepatocellular carcinoma (HCC). Currently, there are no FDA-approved drugs for NAFLD progression to NASH, while the first-line treatments for HCC exhibit limited effectiveness and high rates of severe adverse reactions. Therefore, pinpointing pathogenic sphingolipids and exploiting sphingolipid-based therapeutic avenues remain pressing concerns in liver research.
See less
See moreSphingolipids are a class of essential lipids, serving as both building blocks of the cell membrane that facilitate cell growth and proliferation and acting as signalling molecules that dictate various cell functions. The liver stands as the primary site for sphingolipid metabolism in our bodies. Conversely, dysregulation of sphingolipids has been implicated in a broad range of liver diseases, such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic hepatosteatosis (NASH) and hepatocellular carcinoma (HCC). Currently, there are no FDA-approved drugs for NAFLD progression to NASH, while the first-line treatments for HCC exhibit limited effectiveness and high rates of severe adverse reactions. Therefore, pinpointing pathogenic sphingolipids and exploiting sphingolipid-based therapeutic avenues remain pressing concerns in liver research.
See less
Date
2024Rights statement
The author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.Faculty/School
Faculty of Medicine and Health, School of Medical SciencesDepartment, Discipline or Centre
Centenary Institute of Cancer Medicine and Cell BiologyAwarding institution
The University of SydneyShare